PMID- 30073169 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 2296-889X (Print) IS - 2296-889X (Electronic) IS - 2296-889X (Linking) VI - 5 DP - 2018 TI - LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion. PG - 67 LID - 10.3389/fmolb.2018.00067 [doi] LID - 67 AB - Monocyte adhesion is a crucial step in transmigration and can be induced by lipopolysaccharide (LPS). Here, we studied the role of mammalian target of rapamycin (mTOR) complexes, mTORC1 and mTORC2, and PKC in this process. We used THP-1 cells, a human monocytic cell line, to investigate monocyte adhesion under static and flow conditions. We observed that 1.0 mug/mL LPS increased PI3K/mTORC2 pathway and PKC activity after 1 h of incubation. WYE-354 10(-6) M (mTORC2/mTORC1 inhibitor) and 10(-6) M wortmannin avoided monocyte adhesion in culture plates. In addition, WYE also blocked LPS-induced CD11a expression. Interestingly, rapamycin and WYE-354 blocked both LPS-induced monocyte adhesion in a cell monolayer and actin cytoskeleton rearrangement, confirming mTORC1 involvement in this process. Once activated, PKC activates mTORC1/S6K pathway in a similar effect observed to LPS. Activation of the mTORC1/S6K pathway was attenuated by 10(-6) M U0126, an MEK/ERK inhibitor, and 10(-6) M calphostin C, a PKC inhibitor, indicating that the MEK/ERK/TSC2 axis acts as a mediator. In agreement, 80 nM PMA (a PKC activator) mimicked the effect of LPS on the activation of the MEK/ERK/TSC2/mTORC1/S6K pathway, monocyte adhesion to ECV cells and actin cytoskeleton rearrangement. Our findings show that LPS induces activation of mTOR complexes. This signaling pathway led to integrin expression and cytoskeleton rearrangement resulting in monocyte adhesion. These results describe a new molecular mechanism involved in monocyte adhesion in immune-based diseases. FAU - Ribeiro, Marcelle C AU - Ribeiro MC AD - Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. FAU - Peruchetti, Diogo B AU - Peruchetti DB AD - Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. FAU - Silva, Leandro S AU - Silva LS AD - Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. FAU - Silva-Filho, Joao L AU - Silva-Filho JL AD - Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. FAU - Souza, Mariana C AU - Souza MC AD - Fundacao Oswaldo Cruz, Instituto de Tecnologia em Farmacos, Rio de Janeiro, Brazil. FAU - Henriques, Maria das Gracas AU - Henriques MDG AD - Fundacao Oswaldo Cruz, Instituto de Tecnologia em Farmacos, Rio de Janeiro, Brazil. FAU - Caruso-Neves, Celso AU - Caruso-Neves C AD - Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. AD - Instituto Nacional de Ciencia e Tecnologia em Medicina Regenerativa, Rio de Janeiro, Brazil. FAU - Pinheiro, Ana Acacia S AU - Pinheiro AAS AD - Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. LA - eng PT - Journal Article DEP - 20180718 PL - Switzerland TA - Front Mol Biosci JT - Frontiers in molecular biosciences JID - 101653173 PMC - PMC6058081 OTO - NOTNLM OT - adhesion OT - human acute monocytic leukemia cell line OT - lipopolysaccharide OT - mTORC1 OT - mTORC2 OT - monocyte OT - phorbol ester OT - protein kinase C EDAT- 2018/08/04 06:00 MHDA- 2018/08/04 06:01 PMCR- 2018/01/01 CRDT- 2018/08/04 06:00 PHST- 2017/11/01 00:00 [received] PHST- 2018/06/28 00:00 [accepted] PHST- 2018/08/04 06:00 [entrez] PHST- 2018/08/04 06:00 [pubmed] PHST- 2018/08/04 06:01 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 10.3389/fmolb.2018.00067 [doi] PST - epublish SO - Front Mol Biosci. 2018 Jul 18;5:67. doi: 10.3389/fmolb.2018.00067. eCollection 2018.